U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders

Loading news article.

U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders | WAPE

U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders

Article summary

Related companies

Comments —